Literature DB >> 11356233

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

E Sherwood Brown1, T Suppes, B Adinoff, N Rajan Thomas.   

Abstract

Bipolar disorder is a common, severe and cyclic psychiatric illness. A strong association between alcohol dependence and bipolar disorder has been reported in numerous studies. The abuse of other drugs including cocaine, amphetamines, opiates, cannabis, and prescription medications in bipolar patients is also an important public health concern and has been less extensively investigated. This review examines the abuse of drugs other than alcohol or nicotine in people with bipolar disorder. The high rates of milder affective symptoms but not mania observed in patients in drug abuse treatment settings suggests the symptoms may in many cases be associated with the drug use. However, such patients presenting in psychiatric settings might be suffering from cyclothymic and related attenuated bipolar disorders (type II). Substance abuse may be associated with medication non-compliance, more mixed or dysphoric mania and possibly an earlier onset of affective symptoms and more hospitalizations. The pharmacotherapy of patients with bipolar disorder and drug abuse is examined, including evidence on the use of mood stabilizers, neuroleptics and the newer atypical antipsychotics in this population.

Entities:  

Mesh:

Year:  2001        PMID: 11356233     DOI: 10.1016/s0165-0327(00)00169-5

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  22 in total

1.  Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.

Authors:  K Gao; D E Kemp; C Conroy; S J Ganocy; R L Findling; J R Calabrese
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

Review 2.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 3.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

4.  Incurring greater health care costs: risk stratification of employees with bipolar disorder.

Authors:  Richard A Brook; Krithika Rajagopalan; Nathan L Kleinman; James E Smeeding; Truman J Brizee; Harold H Gardner
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

5.  No evidence for association between 19 cholinergic genes and bipolar disorder.

Authors:  Jiajun Shi; Eiji Hattori; Hongwei Zou; Judith A Badner; Susan L Christian; Elliot S Gershon; Chunyu Liu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-09-05       Impact factor: 3.568

6.  Ethnicity and diagnostic patterns in veterans with psychoses.

Authors:  Frederic C Blow; John E Zeber; John F McCarthy; Marcia Valenstein; Leah Gillon; C Raymond Bingham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-10       Impact factor: 4.328

7.  Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach.

Authors:  Brandon A Gaudiano; Lauren M Weinstock; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2011-01       Impact factor: 1.325

8.  Cannabinoid hyperemesis syndrome and the onset of a manic episode.

Authors:  Phillip Gregoire; Michael Tau; David Robertson
Journal:  BMJ Case Rep       Date:  2016-04-27

9.  Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Susan J Wenze; Gary Epstein-Lubow; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2015-10-23       Impact factor: 3.735

Review 10.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.